Standout Papers
Citation Impact
Citing Papers
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
2006
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
2008
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
2007
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
2011
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
2014
Gastrin-Releasing Peptide (GRP) Analogues for Cancer Imaging
2004
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
2011
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Acromegaly
2006 Standout
Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness
2005
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long‐term analysis of 132 patients
2007
Cancer to bone: a fatal attraction
2011 Standout
T1G3 Bladder Tumours: The Case for Radical Cystectomy
2003
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high‐grade bladder cancer? A long‐term follow‐up of a randomized study
2007
Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
2001
The effect of age and gender on bladder cancer: a critical review of the literature
2009
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
2011
Bladder cancer in the elderly
2009
To differentiate or not — routes towards metastasis
2012
[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
2012
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
2011
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model
2002
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
2011
In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
2011
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Advances in Brain Tumor Surgery
2007
TGFβ signalling: a complex web in cancer progression
2010
A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
2009
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Bladder Preservation Strategies
2014
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies
2008
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
2001
The dark side of a tumor suppressor: anti-apoptotic p53
2008
Regulation of cancer cell metabolism
2011 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy
2013
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ
2005
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Secretory meningioma
1997
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Plasma osteopontin
2002
Malignant Gliomas in Adults
2008 Standout
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: Novel post-transcriptional, post-translational regulation
2005
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Outcomes of Patients with Clinical T1 Grade 3 Urothelial Cell Bladder Carcinoma Treated with Radical Cystectomy
2008
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
2013
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update
2003
Primary brain tumours in adults
2012 Standout
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
2006
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma
2003
Osteopontin: An Effector and an Effect of Tumor Metastasis
2010
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?
2007
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Clinical Indications and Outcomes with Nerve-sparing Cystectomy in Patients with Bladder Cancer
2005
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
2007
The tumor microenvironment and metastatic disease
2008
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Mechanisms governing bone metastasis in prostate cancer
2001
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
2010
True radiotracers: Cu-64 targeting vectors based upon bombesin peptide
2009
Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
1997
PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata
2007
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
Brain Tumors
2001 Standout
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies
2009
Evaluation of 64Cu-Labeled Bifunctional Chelate–Bombesin Conjugates
2011
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
2016
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
2008
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
Memory--a Century of Consolidation
2000 StandoutScience
Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
2008
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients
2011
Hydrogels for Tissue Engineering
2001 Standout
Bladder Cancer
2020 Standout
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
2016
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
PROGNOSTIC FACTORS OF OUTCOME AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A RETROSPECTIVE STUDY OF A HOMOGENEOUS PATIENT COHORT
1999
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
2014
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPING
2004
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710
2014
Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
2002
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
2003
Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
2006
Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
2005
The phosphatidylinositol‐3 kinase pathway regulates bladder cancer cell invasion
2003
Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis
2012
Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
2010
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
2005
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Immunocompatibility and biocompatibility of cell delivery systems
2000
Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
2013
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
[ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
2007
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases
1997
Osteopontin at the Crossroads of Inflammation and Tumor Progression
2017
Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks
2008
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the 111In-DOTA-X-BBN(7−14)NH2 Structural Paradigm in a Prostate Cancer Model
2008
Works of Regula Markwalder being referenced
Invasion depth is the most important prognostic factor for transitional‐cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy
1994
BMP7, a Putative Regulator of Epithelial Homeostasis in the Human Prostate, Is a Potent Inhibitor of Prostate Cancer Bone Metastasis in Vivo
2007
Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon
1994
Immunohistochemical determination of p53 overexpression
1997
Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy
1990
Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor
2005
Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?
2002
PRIMARY T1G3 BLADDER CANCER: ORGAN PRESERVING APPROACH OR IMMEDIATE CYSTECTOMY?
2004
Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
1999
Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features
1983
Long-term Experience With Bacillus Calmette-Guerin Therapy of Upper Urinary Tract Transitional Cell Carcinoma in Patients Not Eligible for Surgery
2002
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
Estrogen and progestin receptors in acoustic and spinal neurilemmomas.
1986
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Osteopontin: possible role in prostate cancer progression.
1999
Adjuvant Cisplatin Chemotherapy Following Cystectomy for Bladder Cancer: Results of a Prospective Randomized Trial
1994
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
Somatostatin receptors in human prostate and prostate cancer.
1995
Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
1995
Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
1999
Disease Progression and Survival of Patients With Positive Lymph Nodes After Radical Prostatectomy. Is there a Chance of Cure?
2003
TISSUE MICROARRAY ANALYSIS OF hMSH2 EXPRESSION PREDICTS OUTCOME IN MEN WITH PROSTATE CANCER
2005